In patients with Inflammatory Bowel Disease (IBD), in whom the incidence of sarcopenia is 42%, sarcopenia is associated with altered GM and increased levels of the gut inflammatory markers fecal calprotectin, lactoferrin and S100A12 [22–25]. This evidence concerns the gene S100A12 and sarcopenia.